Clinical Trials Logo

Thrombophilia clinical trials

View clinical trials related to Thrombophilia.

Filter by:

NCT ID: NCT00683397 Completed - Clinical trials for Venous Thromboembolism

Frankfurt Thrombophilia Registry

Start date: May 2008
Phase: N/A
Study type: Observational

Consecutive patients with acute or previous venous thromboembolism are enrolled in this registry. Using a standardized questionnaire, clinical data detailing venous thromboembolism and contributing VTE risk factors are recorded. Results of technical and laboratory investigations including screening for thrombophilic disorders were additionally entered into the database.

NCT ID: NCT00485446 Completed - Clinical trials for Thrombophilia, Thyroid Autoimmunity

Thrombophilia and Thyroid Autoimmunity in Implantation Failure and Recurrent Miscarriage

Start date: n/a
Phase: N/A
Study type: Observational

This study was designed to evaluate the incidence of both, inherited and adquired thrombophilia, and thyroid autoinmunity in unknown infertility (UI), implantation failure (IF) and recurrent miscarriage (RM). To focus on these particular disorders and to rule out another potential confounding variables, 4 particular groups of women were created. Only young women (< 38 years old), patients whose previous preimplantation genetic screening (PGS) cycles displayed an acceptable rate of aneploidies, and women without organic uterine abnormality, autoimmune disease or endocrine disorder were included in the study.

NCT ID: NCT00457184 Completed - Migraine Clinical Trials

Thrombophilia and Migraine, Are They Related?

Start date: January 2004
Phase: N/A
Study type: Observational

Migraine was described as related to stroke in adults and children as well. Complete thrombophilic status was not study in large groups of pediatric patients. The purpose of our study is to assess the prethrombotic profile among children and teenagers diagnosed as suffering from migraine attacks.

NCT ID: NCT00210197 Completed - Breast Cancer Clinical Trials

Hypercoagulability After Breast Cancer Surgery

EHC
Start date: January 2005
Phase: N/A
Study type: Observational

The risk of deep venous thrombosis after radical breast surgery is known. The objective of this study is to explore hypercoagulability after radical breast cancer surgery by studying several factors for haemostasis before, during and after surgery. Ultrasound Doppler examination is realised between 24 and 72 hours post-operatively. Hypercoagulability is defined by a significant increasing level of thrombin-antithrombin, D-dimer and the endogen thrombin potential.